Neurotechnology firm Dreem snags $35 mln
Paris and San Francisco-based Dreem, a neurotechnology company, has secured $35 million in funding. The lead investors were Johnson & Johnson Innovation - JJDC and Bpifrance.
28 June 2018•1 min read
Paris and San Francisco-based Dreem, a neurotechnology company, has secured $35 million in funding. The lead investors were Johnson & Johnson Innovation - JJDC and Bpifrance.
